Moderna said its phase three study of the mRNA-1273 vaccine was 94.5% effective. By the end of 2020, the company expects to have approximately 20 million doses of mRNA-1273 ready to ship in the US and...
Already have an account? Sign in here
Unlock the most comprehensive mining finance news with MiningNews.net
Looking for the industry's top publication for ASX-listed mining activities and market trends? MiningNews.net gives you instant access to breaking news, resources and commodities updates, and award-winning, expert commentary.
- NEXT: Nexus raises over $7M
- PREVIOUS: News Wrap
